Skip to main content
Fig. 2 | World Journal of Surgical Oncology

Fig. 2

From: Efficacy of transarterial therapy combined with first-line tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a network meta-analysis

Fig. 2

Network graph of the outcomes. A Network graph of overall survival. B Network graph of progression-free survival. C Network graph of time to progression. D Network graph of objective response rate evaluated by mRECIST criteria. E Network graph of disease controlled rate evaluated by mRECIST criteria. F Network graph of adverse event. G Network graph of objective response rate evaluated by RECIST criteria. H Network graph of disease controlled rate evaluated by RECIST criteria

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us